For example, JAK2 mutations in leukemia cells can lead to the production of cytokines and growth factors such as IL-6, IL-10, and GM-CSF, which not only stimulate leukemia cell proliferation but also recruit immunosuppressive cells, like regulatory T-cells (Tregs), to the tumor microenvironment. Here, JAK2 is linked to neoplasm.